Cargando…
Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer
Thyroid cancer (TC) is the most prevalent malignancy of the endocrine system. PANoptosis, a newly discovered cell death pathway, is of interest in tumor research. However, the relationship between PANoptosis-related lncRNAs (PRlncRNAs) and TC remains unclear. The study aimed to develop a prognostic...
Autores principales: | Li, Ruowen, Zhao, Mingjian, Sun, Min, Miao, Chengxu, Lu, Jinghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476615/ https://www.ncbi.nlm.nih.gov/pubmed/37671354 http://dx.doi.org/10.7717/peerj.15884 |
Ejemplares similares
-
A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020) -
A robust immune-related lncRNA signature for the prognosis of human colorectal cancer
por: Zhu, Gongmin, et al.
Publicado: (2022) -
A DCS-related lncRNA signature predicts the prognosis and chemotherapeutic response of patients with gastric cancer
por: Zhang, Yang, et al.
Publicado: (2022) -
A seven-lncRNA signature for predicting Ewing’s sarcoma
por: Chen, Zhihui, et al.
Publicado: (2021) -
Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)